{"id":"NCT04535531","sponsor":"Novan, Inc.","briefTitle":"A Phase 3 Molluscum Contagiosum Efficacy and Safety Study","officialTitle":"A Phase 3 Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study Comparing the Efficacy and Safety of SB206 and Vehicle Gel Once Daily in the Treatment of Molluscum Contagiosum","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-09-01","primaryCompletion":"2021-04-28","completion":"2021-07-28","firstPosted":"2020-09-02","resultsPosted":"2023-01-26","lastUpdate":"2023-01-26"},"enrollment":891,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Molluscum Contagiosum"],"interventions":[{"type":"DRUG","name":"SB206 10.3% berdazimer","otherNames":["SB206 12% berdazimer sodium"]},{"type":"DRUG","name":"vehicle gel","otherNames":[]}],"arms":[{"label":"SB206 10.3% berdazimer","type":"EXPERIMENTAL"},{"label":"vehicle gel","type":"PLACEBO_COMPARATOR"}],"summary":"This is a phase 3 multi-center, randomized, double-blind, vehicle-controlled, parallel group study to be conducted in up to approximately 850 subjects 6 months of age and older with molluscum contagiosum (MC). Subjects or their caregivers will apply SB206 10.3% or Vehicle Gel once daily for a minimum of 4 weeks and up to 12 weeks to all lesions identified at Baseline and new treatable lesions that arise during the course of the study.","primaryOutcome":{"measure":"Complete Clearance of All Treatable MC at Week 12","timeFrame":"12 Weeks","effectByArm":[{"arm":"SB206","deltaMin":144,"sd":null},{"arm":"Placebo","deltaMin":88,"sd":null}],"pValues":[]},"eligibility":{"minAge":"6 Months","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":55,"countries":["United States"]},"refs":{"pmids":["36287306","35830173"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":444},"commonTop":["Application site pain","Application site erythema","Application site pruritus","Application site dermatitis","Application site exfoliation"]}}